Current methods for the diagnosis and monitoring of bladder cancer are invasive, and might lack the sensitivity required for detection of all types of bladder cancer. Here, authors describe the proteomic identification of biomarkers of urinary bladder cancer, findings of studies investigating individual biomarker proteins and/or panels and the clinical potential of proteomic biomarkers for the diagnosis and management of patients with bladder cancer.
- Maria Frantzi
- Agnieszka Latosinska
- Antonia Vlahou
